| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin.
|
J Pharmacol Exp Ther
|
2002
|
2.12
|
|
2
|
Local anesthetic-induced conduction block and nerve fiber injury in streptozotocin-diabetic rats.
|
Anesthesiology
|
1992
|
1.76
|
|
3
|
Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.
|
J Exp Med
|
1995
|
1.17
|
|
4
|
Prosaptide prevents paclitaxel neurotoxicity.
|
Neurotoxicology
|
1998
|
1.09
|
|
5
|
Regulation of expression of the sensory neuron-specific sodium channel SNS in inflammatory and neuropathic pain.
|
Mol Cell Neurosci
|
1997
|
1.05
|
|
6
|
Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation: lack of a role in allodynia development.
|
J Neurosci
|
1999
|
1.00
|
|
7
|
GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice.
|
Diabetes Obes Metab
|
2011
|
0.99
|
|
8
|
Gabapentin prevents hyperalgesia during the formalin test in diabetic rats.
|
Neurosci Lett
|
1999
|
0.93
|
|
9
|
Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.
|
J Neurol Neurosurg Psychiatry
|
1987
|
0.92
|
|
10
|
Effects of treatment with myo-inositol or its 1,2,6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetes.
|
Eur J Pharmacol
|
1993
|
0.89
|
|
11
|
Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab).
|
J Peripher Nerv Syst
|
2014
|
0.89
|
|
12
|
Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
|
Diabetes
|
1998
|
0.88
|
|
13
|
TX14(A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactose-fed rats.
|
J Neuropathol Exp Neurol
|
2001
|
0.87
|
|
14
|
Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats.
|
J Peripher Nerv Syst
|
1999
|
0.87
|
|
15
|
Necrotizing myopathy induced by overexpression of interferon-gamma in transgenic mice.
|
Muscle Nerve
|
1999
|
0.86
|
|
16
|
Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.
|
Diabetologia
|
1987
|
0.84
|
|
17
|
Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition.
|
J Auton Nerv Syst
|
1996
|
0.83
|
|
18
|
Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats.
|
Diabetologia
|
2006
|
0.83
|
|
19
|
BDNF attenuates functional and structural disorders in nerves of galactose-fed rats.
|
J Neuropathol Exp Neurol
|
1997
|
0.82
|
|
20
|
Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats.
|
Diabetologia
|
1991
|
0.82
|
|
21
|
Prosaposin-derived peptides enhanced sprouting of sensory neurons in vitro and induced sprouting at motor endplates in vivo.
|
J Peripher Nerv Syst
|
2000
|
0.81
|
|
22
|
Prosaposin is immunolocalized to muscle and prosaptides promote myoblast fusion and attenuate loss of muscle mass after nerve injury.
|
Muscle Nerve
|
2001
|
0.81
|
|
23
|
Polyol pathway and osmoregulation in JS1 Schwann cells grown in hyperglycemic and hyperosmotic conditions.
|
Am J Physiol
|
1996
|
0.80
|
|
24
|
Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats.
|
Diabetes
|
1997
|
0.79
|
|
25
|
Mast cell degranulation and blood-nerve barrier permeability in rat sciatic nerve after 7 days of hyperglycemia.
|
Am J Physiol
|
1995
|
0.78
|
|
26
|
Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease.
|
Neuroscience
|
2011
|
0.78
|
|
27
|
Nerve conduction velocity and axonal transport of 6-phosphofructokinase activity in galactose-fed rats.
|
J Neurol Sci
|
1991
|
0.77
|
|
28
|
Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
|
J Neurol Sci
|
1989
|
0.77
|
|
29
|
Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats.
|
Neurosci Lett
|
1993
|
0.77
|
|
30
|
Effects of sorbinil treatment in rats with chronic streptozotocin-diabetes; changes in lens and in substance P and catecholamines in the iris.
|
Curr Eye Res
|
1989
|
0.76
|
|
31
|
Sorbitol accumulation and transmembrane efflux in osmotically stressed JS1 schwannoma cells.
|
Neurosci Lett
|
1997
|
0.76
|
|
32
|
Neonatal capsaicin treatment abolishes formalin-induced spinal PGE2 release.
|
Neuroreport
|
1997
|
0.76
|
|
33
|
Decreased endoneurial fluid electrolytes in normal rat sciatic nerve after aldose reductase inhibition.
|
J Neurol Sci
|
1993
|
0.75
|
|
34
|
Dose-dependent alterations in nerve polyols and (Na+,K+)-ATPase activity in galactose intoxication.
|
Metabolism
|
1991
|
0.75
|
|
35
|
Effects of hindlimb temperature on sciatic nerve laser Doppler vascular conductance in control and streptozotocin-diabetic rats.
|
J Neurol Sci
|
1999
|
0.75
|
|
36
|
The effect of alpha-trinositol (D-myo-inositol 1,2,6-trisphosphate) on formalin-evoked spinal amino acid and prostaglandin E2 levels.
|
Brain Res
|
1997
|
0.75
|
|
37
|
Effects of seven days of galactose feeding and aldose reductase inhibition on mast cells and vessel morphometry in rat sciatic nerve.
|
J Neurol Sci
|
1996
|
0.75
|